Covered recipient · General Payments record
KATHLEEN A MAHER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2023
$2,637.44
- Reported across 172 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $613.36 | 28 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $180.56 | 9 |
| Acerta Pharma LLC | $122.83 | 1 |
| Novo Nordisk AS | $96.11 | 6 |
| Takeda Pharmaceuticals U.S.A., Inc. | $50.73 | 3 |
| ITI, Inc. | $36.22 | 2 |
| Bausch Health US, LLC | $35.53 | 2 |
| PFIZER INC. | $22.81 | 1 |
| DEXCOM, INC. | $21.52 | 1 |
| QOL Medical, LLC | $19.62 | 1 |
| Amarin Pharma Inc. | $14.49 | 1 |
| Amgen Inc. | $12.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $9.30 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006067773 | CMS |
| ABBVIE INC. | $113.96 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006067775 | CMS |
| ABBVIE INC. | $8.43 | 02/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006067777 | CMS |
| ABBVIE INC. | $2.86 | 03/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006067779 | CMS |
| ABBVIE INC. | $3.64 | 03/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006067781 | CMS |
| ABBVIE INC. | $13.00 | 03/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006067783 | CMS |
| ABBVIE INC. | $11.93 | 05/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006067785 | CMS |
| ABBVIE INC. | $6.09 | 05/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006067787 | CMS |
| ABBVIE INC. | $11.35 | 06/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006067789 | CMS |
| Amarin Pharma Inc. | $14.49 | 06/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000919469 | CMS |
| Amgen Inc. | $12.94 | 02/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020760065 | CMS |
| AstraZeneca Pharmaceuticals LP | $122.83 | 02/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1015337249 | CMS |
| Bausch Health US, LLC | $19.73 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1046994523 | CMS |
| Bausch Health US, LLC | $15.80 | 07/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1046994533 | CMS |
| Dexcom, Inc. | $21.52 | 05/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054848697 | CMS |
| ITI, Inc. | $17.23 | 03/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1041009181 | CMS |
| ITI, Inc. | $18.99 | 03/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1041009187 | CMS |
| Novo Nordisk Inc | $16.15 | 01/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000691595 | CMS |
| Novo Nordisk Inc | $17.79 | 01/26/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000691615 | CMS |
| Novo Nordisk Inc | $17.35 | 02/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000691605 | CMS |
| Novo Nordisk Inc | $15.29 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000691585 | CMS |
| Novo Nordisk Inc | $15.12 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000691575 | CMS |
| Novo Nordisk Inc | $14.41 | 05/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000691565 | CMS |
| PFIZER INC. | $22.81 | 04/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049169985 | CMS |
| QOL Medical, LLC | $19.62 | 03/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1059298915 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.96 | 03/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055951437 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.82 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055951441 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.95 | 06/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1055951445 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.